This Wednesday, November 11, the European Commission and the Pfizer and BionTech laboratories have reached an agreement on the delivery of 300 million vaccines in Europe.
Delivery of 300 million vaccines in Europe
The European Union has ordered 300 million doses of the future vaccine against Covid-19, insured as ” 90% efficient “. In detail, 200 million doses ordered, with an option for 100 million additional doses. ” If the BNT162b2 vaccine candidate receives authorization from the European Medicines Agency, the European Commission will lead the vaccine dose allocation process among the EU Member States that have been selected to receive the vaccine under this agreement. Added Pfizer and BionTech. The 27 countries of the European Union should pay less than 19.50 dollars (16.60 euros) per dose of vaccine, a price reserved for the United States, in particular because Europe has provided support for research into the vaccine.
European Health Commissioner Stella Kyriakides said “ even when we have a safe and effective vaccine, it will not be the panacea that will make Covid-19 disappear in a day “. In particular, the European Union wants to ensure that it has several vaccines available, and has therefore already made agreements with the Swedish-British AstraZeneca, the American Johnson & Johnson and the Franco-British duo Sanofi-GSK.
When will the population be vaccinated?
” Deliveries are expected to start by the end of the year depending on clinical success and authorizations from regulatory authorities »Announced the two pharmaceutical groups. According to estimates by Andrea Ammon, director of the European epidemic agency, Europe could start the vaccination campaign in the first quarter of 2021, while the United States is considering it before the end of the year. According to the BBC, the British government is even more optimistic with vaccinations as of December 1.
